Expansion of Rare Disease Genetic Testing Driven by Increased Diagnostic Demand
The expansion of rare disease genetic testing is being driven by increasing diagnostic demand, as governments and healthcare organizations recognize the benefits of earlier diagnosis. This trend is particularly evident in Europe and Asia Pacific, where healthcare systems are emphasizing rare disease diagnosis to improve patient outcomes and healthcare efficiency. The adoption of genetic testing is expanding to support precision medicine approaches, with healthcare providers integrating advanced molecular diagnostics. The market for inherited metabolic disorder diagnostics is also growing due to expanded newborn screening programs and increased genetic testing. Additionally, reproductive genetic testing is expanding with advancements in technology and rising awareness of genetic disorders among prospective parents. 
